Global Pneumonia Therapeutics Market 2017-2021

Overview of the global pneumonia therapeutics market

The emergence of advanced diagnostic techniques such as the use of biomarkers for diagnosing pneumonia has improved the identification rate of respiratory infections. The molecular diagnostic technique aids in understanding the outbreak and transmission of disease. Technavio’s market research study has identified the emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. The emergence of advanced diagnosis provides various benefits such as improved organism quantification, differentiation, and typing and profiling of antibiotic resistance. With the growing need for early and precise diagnosis there is an increasing demand for drugs to treat pneumonia, which in turn, fuels market growth. Our market research analysts have estimated that this market will grow steadily at a CAGR of almost 7% by 2021.

There is an increasing prevalence of respiratory tract infections such as community-acquired pneumonia (CAP) and ventilator-associated pneumonia (VAP). CAP is one of the major causes of mortality and morbidity and the increase in such cases is mainly due to the rising concerns about antibiotic resistance. This induces the need for clinical studies for the treatment of CAP and VAP, which further contributes to the demand for pneumonia therapeutic drugs. According to our analysts, the rise in respiratory infection cases will be one of the key trends a that will have a positive impact on the pneumonia therapeutics market in the coming years.

Competitive landscape and key vendors

The pneumonia therapeutics market is moderately fragmented owing to the presence of several international, regional, and local vendors. Key vendors in this pneumonia treatment market are investing heavily in R&D to innovate novel drugs. To strengthen their market positions, the players in the pneumonia therapeutics market are following strategic activities such as M&A.

The leading vendors in the market are

• GlaxoSmithKline
• Merck Sharp & Dohme
• Novartis
• Pfizer

The other vendors in the market are AstraZeneca, Bayer, Biotest, Ono Pharmaceutical, and Tetraphase Pharmaceuticals.

Segmentation by product type and analysis of the pneumonia therapeutics market

• Vaccines
• Anti-Infectives
• Oxygen Therapy

The vaccine segment accounts for major share of the pneumonia treatment market due to its high efficiency in the prophylaxis of pneumonia and its cost-effectiveness. The high annual cost for drug therapy and the increased awareness and need for the prevention of pneumonia, will contribute to the growth of the pneumonia therapeutics market in this segment.

Geographical segmentation and analysis of the pneumonia therapeutics market

• Americas
• APAC
• EMEA

The Americas will be the major revenue contributor to the pneumonia therapeutics market due to the availability of an excellent infrastructure and the presence of developed economies. This region consists of several major key players that are actively engaged in launching new and innovative products. Additionally, the increasing health awareness and the initiatives taken for the prevention of pneumonia will further contribute to the growth of the pneumonia treatment market in this region.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global pneumonia therapeutics market?
• What are the key market trends impacting the growth of the global pneumonia therapeutics market?
• What are the challenges to market growth?
• Who are the key vendors in the global pneumonia therapeutics market?
• What are the market opportunities and threats faced by the vendors in the global pneumonia therapeutics market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global pneumonia therapeutics market?

Technavio also offers customization on reports based on specific client requirement.